Literature DB >> 34101963

Intracellular Protein-Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates.

Rivkah Rogawski1, Adi Rogel2, Itai Bloch3, Maayan Gal4, Amnon Horovitz2, Nir London2, Michal Sharon1.   

Abstract

Understanding protein-ligand interactions in a cellular context is an important goal in molecular biology and biochemistry, and particularly for drug development. Investigators must demonstrate that drugs penetrate cells and specifically bind their targets. Towards that end, we present a native mass spectrometry (MS)-based method for analyzing drug uptake and target engagement in eukaryotic cells. This method is based on our previously introduced direct-MS method for rapid analysis of proteins directly from crude samples. Here, direct-MS enables label-free studies of protein-drug binding in human cells and is used to determine binding affinities of lead compounds in crude samples. We anticipate that this method will enable the application of native MS to a range of problems where cellular context is important, including protein-protein interactions, drug uptake and binding, and characterization of therapeutic proteins.
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Entities:  

Keywords:  analytical methods; drug discovery; drug screening; mass spectrometry; protein analysis

Year:  2021        PMID: 34101963     DOI: 10.1002/anie.202104947

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

Review 1.  Approaches to Heterogeneity in Native Mass Spectrometry.

Authors:  Amber D Rolland; James S Prell
Journal:  Chem Rev       Date:  2021-09-01       Impact factor: 72.087

2.  A Liquid Chromatography-Mass Spectrometry Method to Study the Interaction between Membrane Proteins and Low-Molecular-Weight Compound Mixtures.

Authors:  Hideo Ogiso; Ryoji Suno; Takuya Kobayashi; Masashi Kawami; Mikihisa Takano; Masaru Ogasawara
Journal:  Molecules       Date:  2022-07-30       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.